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Background & objective: Genetic factors could play an important role in the outcome of pregnancy. 
This study was carried out to identify risk factors that result in adverse pregnancy outcome and to 
develop a system of screening and referral to a tertiary hospital equipped with facilities for diagnosis and 
management of such high risk pregnancies. 
Methods: District level hospitals close to the participating centers e.g. All India Institute of Medical Sciences, 
New Delhi, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, BJ Medical College,  
Pune, St. John Medical College, Bangalore and Genetic Research Center, (ICMR), Mumbai, were selected. 
Pregnant women < 28 wk gestation attending antenatal OPD of selected district hospitals were included. All 
eligible women who gave consent for participation in the study, were screened using a predesigned proforma 
based on family history, past pregnancy history, history of genetic disease/ congenital malformation in 
previous child and history of present pregnancy. Pregnancy outcome was noted. 
Results: There was statistically significant difference in the outcome of pregnancy in the following groups: 
(i) past pregnancy history of 3 or more spontaneous abortions (RR= 3.9; CI=1.17-9.02); (ii) still birth 
(RR= 2.5; CI= 1.41-4.48); (iii) previous child with neurol tube defect (NTD) (RR=2.3; CI= 1.22- 4.60); 
and (iv) previous child with congenital malformation (RR=2.2; CI = 1.11- 4.35). 
Interpretation & conclusion: A sample questionnaire may be used for screening of pregnant women at 
risk of having and adverse outcome. Also screening of pregnant women for thalassaemia carrier state 
and maternal serum α-foetoprotein (AFP) for NTD may be useful.
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 The primary focus of antenatal care has been health 
of the mother during pregnancy and safe delivery 
of the child. Foetal medicine is now emerging as an 
equally important component of the antenatal care1. 
For this purpose not only the scope of antenatal care 
needs to be enlarged to include foetal health but also to 
add the concept of preconceptional clinic with genetic 
counselling. 
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 Adverse pregnancy outcomes comprise foetal 
loss (abortions and still birth), perinatal death, birth 
defects and a child born with genetic disorders. While 
state of mother's health and nutrition are important 
in determining birth weight and perinatal mortality, 
genetic factors play a major role in the causation of 
birth defects and foetal loss. Current estimates indicate 
that about 15-20 per cent of clinically recognized 
pregnancies end up in spontaneous abortion prior 
to 20 wk of gestation, while another 70 per cent of 
fertilized ova do not get implanted2. The major cause 
of spontaneous abortion and foetal loss is chromosomal 
anomaly and genetic defects; 40-60 per cent of first 
trimester abortuses and 10 per cent of second trimester 
abortuses have chromosomal anomaly while 5 per 
cent of perinatal deaths are due to chromosomal and 
other genetic disorders2. In developed countries with 
low infant mortality rates, this load is considerably 
higher2,3.
 Congenital malformations are present in 2-3 per 
cent of live births and in 10 per cent of still births4,5. 
Those who survive with malformations place a heavy 
burden on the society and affected families. Among 
malformations, neural tube defect (NTD) is a major 
malformation in the Indian subcontinent3 which has 
become highly amenable to primary and secondary 
prevention5-10. Its prevalence is high in northern India, 
northern China, Egypt and Lebanon11. Anencephaly 
and spina bifida comprising a vast majority of NTD are 
common congenital abnormalities, which contribute 
substantially to morbidity and mortality  in infancy and 
childhood. One out of four affected foetuses is stillborn 
and one out of two results in spontaneous abortion12,13. 
The risk of recurrence of NTD after birth of an affected 
child is 3-5 per cent which is 10 times higher than 
that of general population14. Other disorders need 
careful diagnosis and genetic counselling. There is 
paucity of information on women attending antenatal 
outpatient department of district hospitals who are 
at risk of having adverse outcome of pregnancy. 
This study was undertaken to determine the relative 
frequency of genetic risk factors which may result in 
adverse pregnancy outcome and to develop a system 
of screening and referral to a hospital equipped with 
management of such high risk pregnancies to improve 
pregnancy outcome. 
Material & Methods 
Selection of centres: The study was carried out at five 
tertiary level hospitals having genetic centres, namely 
the All India Institute of Medical Sciences (AIIMS), 
New Delhi, Sanjay Gandhi Post Graduate Institute of 
Medical Sciences (SGPGIMS), Lucknow, BJ Medical 
College, Pune, St. John Medical College, Bangalore 
and Genetic Research Centre (ICMR), Mumbai. Each 
centre selected a district level or equivalent peripheral 
hospital, with active obstetric service. All pregnant 
women below 28 wk of gestation enrolled for antenatal 
care at these hospitals during the year 1995-1996 were 
taken up for the study. Mumbai centre selected the Thane 
Civil Hospital, and five primary health centres in the 
Thane district for the study. Bangalore centre selected 
one of the City Corporation Hospitals, which was, 
located 7 kilometers away from the St. John's Medical 
College. AIIMS selected the Faridabad Hospital, and 
the Lucknow centre selected the Mahila Hospital, 
Golaganj, which is a Government District Hospital. 
Approval of the study protocol by the Institutional 
Ethics Committee of all the participating institutions 
was obtained prior to initiation of the study.
Inclusion criteria: All women upto 28th wk of gestation, 
attending Obstetrics OPD of the chosen hospital for the 
first time were included in the study. Informed consent 
was obtained from those who agreed to participate 
in the study after being briefed about the purpose of 
the study. After consent, a pre-designed screening 
proforma was filled up (Annexure). Information was 
collected on age of women, family history of genetic 
disease, history of still birth, 3 or more spontaneous 
abortion in the past, 2 or more neonatal deaths, history 
of genetic disease in previous births (e.g., NTD, 
Down syndrome, congenital malformation, mental or 
physical retardation, thalassaemia, bleeding diathesis 
or other genetic syndrome, etc.) and history of systemic 
illnesses/history of infection/exposure to radiation and 
drug intake in the first trimester during the current 
pregnancy. 
 Blood samples (2 ml of EDTA blood from 
NESTROF test and 3 ml of non-ox lood for 
MSAFP) were collected from a subgroup of women 
with known last menstrual period (LMP) between 
13-16 wk of gestation for estimation of maternal serum 
alpha-foetoprotein (MSAFP) and NESTROFT test 
(Naked Eye Single Tube Osmotic Fragility Test) along 
with routine haemogram. MSAFP was estimated by 
ELISA technique using  modification of the method 
of McDonald and Kelly15 to assess the risk of neural 
tube defect and chromosomal abnormality (Down 
Syndrome). Those having MSAFP value of 2 or 
more multiples of median value (MOM) for the given 
gestational age were advised to have an ultrasound 
evaluation done to rule out presence of neural tube 
 ICMR: GENETIC SERVICES IN THE NATIONAL FAMILY WELFARE PROGRAMME IN INDIA  405
Annexure
Contd....
406 INDIAN J MED RES, OCTOBER 2009
defect. Those having MSAFP <0.8 times the median 
value were counselled for the risk of having Down 
syndrome and were offered antenatal diagnosis. 
NESTROFT was done to screen carrier status for beta 
thalassaemia, which was later confirmed by HbA2 
estimation by column chromatography method16. If a 
woman was found to be a carrier for beta thalassaemia, 
her husband was also screened. If the husband was also 
a carrier, the couple was considered at a risk of having 
a foetus with thalassaemia major. The couple was 
then offered antenatal diagnosis by chorionic villous 
sampling. 
Exclusion criteria: Women who enrolled for delivery 
beyond 28 wk of pregnancy or who came as an 
emergency to the labour room were excluded from the 
study. 
 Women enrolled in the study were followed up 
till delivery to record the pregnancy outcome. They 
were advised to come for delivery in the same hospital 
where they were enrolled and those having risk factors 
on screening were given genetic counselling and 
referred to tertiary hospitals for delivery. In case of non 
availability of primary outcome, reply paid cards were 
sent, and home visits were made by social workers to 
collect information on outcome of pregnancy. Outcome 
of pregnancy and condition of newborn among liveborn 
babies was noted.  
 Women having one or more risk factors on 
screening were considered at increased risk for genetic 
disease and those who did not have any risk factor were 
considered low risk. When the outcome of pregnancy 
was spontaneous abortion, still birth, induced abortion 
for NTD, Down syndrome, or thalassaemia, or the 
newborn was found to have congenital malformation/
genetic syndrome, the outcome was considered as 
abnormal.
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Statistical analysis: Data were analyzed using software 
EPI - info version 5 and SPSS version 12.0 Chicago, 
Illinois, USA. Univariate analysis was performed for 
all the variables considered as risk factors for screening. 
Z - test was used for comparing the outcome in the 
two groups viz., the increased risk vs non risk group. 
All variables that achieved significance on univariate 
analysis were identified, and subjected to step-wise 
logistic regression analysis to determine independent 
risk factors associated with adverse outcome of 
pregnancy.
Results 
Demographic and obstetric profile: A total of 8,331 
women were enrolled for the study at the five centres. 
Mean ± SD age of the women was 23.5±3.8 yr. Seventy 
four (0.8 %) women were below 18 yr of age and 39 
(0.5%) above 35 yr. Majority (83.2%) of the women 
enrolled in the study were Hindus at all the centres; 
only at Bangalore centre about half (46.4%) of women 
enrolled were Muslims. Mean gestational age at the 
time of enrollment was 19.8 ± 5.1 wk (range 18.5 ± 
5.8  to 20.8 ± 4.6 wk) at various centres. Frequency of 
consanguinity varied from centre to centre. It was high 
in Bangalore (41.6%) and Pune (27.5%) centres, while 
at Mumbai, Lucknow and Delhi centres it was 14.2, 5.8 
and 0.7 per cent only.
Increased risk for genetic disease: Based on history, 
a total of 1167(14.0%) women were found to be at 
increased risk for genetic disease/abnormal outcome 
of pregnancy, while 7164 (86.0%) women did not have 
any of the listed risk factors. Proportion of women 
with one or more risk factors varied from 10.3 per 
cent in Lucknow to 23.0 per cent in Mumbai. In Delhi, 
Bangalore and Pune these percentages were 11.3, 12.6, 
and 19.4, respectively. Majority of the women (10.5%) 
had single risk factor, while 3.5 per cent had 2 or more 
risk factors (Table I).
Pregnancy outcome: Information on outcome 
of pregnancy was available for a total of 4041 
(48.5%) women enrolled; others were lost to follow up. 
Of these, 794 (19.6%) cases were enrolled at Delhi, 
878 (21.7%) at Mumbai, 459 (11.4%) at Pune, 443 
(11.0%) at Bangalore and 1467 (36.3%) at Lucknow. 
In order to test whether loss to follow up could have 
introduced any bias, two groups viz., those with and 
without information on outcome were compared for 
the prevalence of risk factors. There was no statistically 
significant difference in the two groups indicating that 
loss to follow up was not selective. Of the 4041 women 
on whom outcome information was available, 570 
(14.1%) had one or more risk factors on screening and 
3471 (85.9 %) did not have any risk factor. 
 Laboratory investigations NESTROFT followed by 
HB A2 estimation and MSAFP were carried out in 2548 
cases. Of the 1526 couples screened, 17 (1.1%) were at 
a risk of having a foetus positive for beta thalassaemia 
major. On maternal serum alpha foetoprotein assay, 
221 (8.7%) women were found to have MSAFP value 
< 0.8 MOM; and 170 (6.7%) had  MSAFP >2 MOM 
indicating risk for neural tube defect. 
 Outcome of pregnancy in increased risk and low 
risk groups is given in Table II. Abnormal outcome of 
pregnancy was observed in 11.2 per cent (64/570) cases 
in increased risk group and in 4.9 per cent (171/3471) 
in low risk group, the difference was statistically 
significant (RR=2.3, CI 1.73-3.0). The occurrence 
of spontaneous abortion, induced abortion and still 
birth were 2.8, 3.5, 3.0 per cent respectively in high 
risk group and 0.7, 1.1 and 1.8 per cent respectively 
in low risk group. All the differences were statistically 
significant (P<0.05) except for still birth. Abnormal 
condition in foetus/newborn (presence of Down 
syndrome, congenital malformation and neural tube 
defect) was observed in a total of 54 cases, 17 (3.0%) 
Table I. Centre-wise distribution of women having risk factor on basis of history
Centre                                                    No. of risk factors                                                           Total risk factor
 1 2 3  > 4
Delhi (n=2029) 190 (9.4) 39 (1.9) 0 (0.0) 0 (0.0) 229 (11.3)
Mumbai (n=902) 136 (15.1) 58 (6.4) 14 (1.6) 0 (0.0) 208 (23.0)
Pune (n=1612) 215 (13.3) 64 (4.0) 22 (1.4)  12 (0.7) 313 (19.4)
Bangalore (n=1130) 109 ( 9.6) 27 (2.4) 5 (0.4) 2 (0.2) 143 (12.6)
Lucknow (n=2658) 223 (8.4) 45 (1.7) 5 (0.2) 1 (0.0) 274 (10.3)
Total (n=8331) 873 (10.5) 233 (2.8) 46 (0.6) 11 (0.1) 1167 (14.0)
Values in parentheses are percentages
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in increased risk group and 37(1.1%) in low risk group. 
The differences in the outcome in the newborn in both 
groups were statistically significant (RR = 2.9, CI 1.65 
- 5.14) (Table III). 
 Family history of any disease affecting multiple 
members, congenital malformation, mental retardation, 
treatment for sub fertility/infertility, history of previous 
child with mental retardation, bleeding diathesis, 
muscular dystrophy, transfusion dependant anaemia, 
other genetic diseases, significant maternal illnesses 
(diabetes, epilepsy, thyroid disease, heart disease, TB, 
fever, rashes lymphadenopathy, etc.), drug intake and 
exposure to radiation was not found to be risk factors 
for adverse outcome of pregnancy in this study probably 
due to small numbers in each category. Multivariate 
logistic regression analysis was applied for identifying 
risk factors for adverse pregnancy outcome. The risk 
factors identified for abnormal outcome of pregnancy 
were past history of 3 or more spontaneous abortion 
(RR= 3.9; CI=1.17-9.02), still birth (RR= 2.5; CI= 1.41-
4.48), previous child with NTD (RR=2.3; CI= 1.22- 
4.60), previous child with congenital malformation 
(RR=2.2; CI = 1.11- 4.35) (Table IV). MSAFP level >2 
(RR 7.1, CI 2.63-19.35) was also found to be independent 
risk factor for adverse outcome in the live births.
Discussion 
 It was observed that out of 8331 pregnant women 
attending OPD of five district hospitals  screened, 
1167(14.0 %) were at risk of having adverse pregnancy 
outcome. Genetic factors play a major role in adverse 
pregnancy outcome like foetal wastage and congenital 
malformations. Of the 42 variables used for screening 
for increased risk in pregnant women, past history 
of spontaneous abortion, still birth, previous child 
with NTD/congenital malformation were found to 
be risk factors for adverse outcome of pregnancy. 
Adverse outcome in the previous pregnancy has also 
been observed as most serious risk factor in other 
studies17-20. In a community based prospective study 
where 6275 deliveries (6084 live births, 167 neonatal 
deaths and 150 still births were followed up for a period 
of 3 yr, adverse outcome in the previous pregnancy was 
observed as most serious risk factor18.  In a case control 
study based on the record of the epidemiological 
surveillance system of neural tube defect association 
between history of maternal reproductive loss and the 
risk of anencephaly was evaluated in three Mexican 
States. Mothers of 157 cases of anencephaly and 151 
controls were interviewed about their reproductive 
history and other additional factors. After adjusting for 
confounders, women with a history of miscarriage in 
previous pregnancies were 4.58 times more at risk of 
having a child with anencephaly than those who did not 
have such a history (OR = 4.58, 95% CI 1.22-17.23)19. 
 NTD is the most common congenital malformation 
of CNS. Its prevalence in US and worldwide is 1 in 
100011. Primary prevention of genetic diseases is 
emerging as an important area to improve quality of 
life and prevent disease burden. It requires targeting 
of preventive measures to entire population or to 
individuals with increased risk, if the increased risk 
individuals could be identified by suitable screening 
strategies. Screening for genetic diseases otherwise 
is very expensive if it is applied to whole population. 
Moreover, screening facilities are not always available 
or there is a lack of trained manpower to carry out the 
tests. In this study around half of women screened 
were not available for follow up inspite of maximum 
possible efforts made to obtain traceable address at the 
time of registration. It remained a major challenge to 
reach them through post, or even by personal visit to 
obtain the details of the pregnancy outcome. 
 Initially it was planned that during the first 
year both screening, and genetic counselling cum 
intervention if any, will be done by the Genetic team 
at the district/ peripheral hospital itself. In the second 
year it was proposed to continue screening at the 
selected hospital by the Genetic team but to refer the 
at risk women to the attached tertiary care hospital for 
counselling intervention if any. In the third year it was 
envisaged that screening will also be carried out by the 
local hospitals’ obstetric team. In order to achieve the 
goal, creation of awareness and training of the local 
team was carried out systematically from the very 
beginning. But the experience proved to the contrary. 
During the second year a number of referred at risk 
patients did not reach the tertiary care hospitals, and 
in the third year local hospitals obstetric team did not 
continue with screening because of excess workload 
of routine hospital services. In the end, the genetic 
team continued to provide both the screening and 
counselling-cum-intervention services throughout the 
study period. 
 The study establishes both the need and utility 
of introduction of preventive genetic services in the 
National Family Welfare Programme. At present, it 
has remained as an add on vertical programme. The 
reasons for failure of integration are multiple, primary 
reason being lack of motivation of both pregnant 
women and medical practitioner to accept and adopt 
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Table II. Distribution of risk factors in relation to outcome of pregnancy
Variables Status 
of risk 
factors
Total
(n=4041)
Normal out-
come
(n=3806)
Abnormal 
outcome
(n=235)
P value & 95% 
Confidence 
Interval (CI)
Consanguinity A
P
3505 (86.7)
536 (13.3)
3300 (86.7)
506 (13.3)
205 (87.2)
30 (12.8)
0.89
I. Family history:
Any disease affecting  
multiple members
A
P
4030 (99.7)
11 (0.3)
3797 (99.8)
9 (0.2)
233 (99.1)
2 (0.9)
0.26
Congenital malformation A
P
4017 (99.4)
24 (0.6)
3783 (99.4)
23 (0.6)
234 (99.6)
1 (0.4)
1.00
Mental retardation A
P
4016 (99.4)
25 (0.6)
3784 (99.5)
22 (0.5)
232 (98.7)
3 (1.3)
0.17
II. Past pregnancy history:
3or more spontaneous abortions
(<28 wk)
A
P
4002 (99.2)
39 (1.0)
3776 (99.2)
30 (0.8)
226 (96.2)
9 (3.8)
RR=4.86
(CI 2.33-11.11)
Still birth A
B
3934 (97.4)
107 (2.6)
3717 (97.7)
89 (2.3)
217 (92.4)
18 (7.6)
RR=3.26
(2.01-5.34)
2 or more neonatal death A
P
4005 (99.1)
36 (0.9)
3774 (99.2)
32 (0.8)
231 (98.3)
4 (1.7)
0.15
Treatment for subfertility/infertility A
P
4022 (95.5)
19 (0.5)
3789 (99.6)
17 (0.4)
233 (99.1)
2 (0.9)
0.30
III. Previous child with genetic   
      disease:
Down syndrome
A
P
4001 (99.0)
40 (1.0)
3771 (99.1)
35 (0.9)
230 (97.9)
5 (2.1)
0.13
Neural tube defect A
P
3964 (98.1)
77 (1.9)
3743 (98.3)
63 (1.7)
221 (94.4)
14 (6.0)
RR=3.60
(2.05-6.33)
Bleeding diathesis A
P
4040 (100.0)
1 (0.0)
3805 (99.9)
1 (0.1)
235 (100.0)
0 (0.0)
1.0
Transfusion dependent anaemia A
P
4028 (99.7)
13 (0.3)
3794 (97.7)
12 (0.3)
234 (99.6)
1 (0.4)
0.54
Muscular dystrophy A
P
4039 (99.9)
2 (0.1)
3804 (99.9)
2 (0.1)
235 (100.0)
0 (0.00)
>0.05
Congenital malformation A
P
3964 (98.1)
77 (1.9)
3743 (98.3)
63 (1.7)
221 (94.0)
14 (6.0)
RR=3.60
(2.05-6.33)
Mental retardation A
P
4007 (99.2)
34 (0.8)
3776 (99.2)
30 (0.8)
231 (98.3)
4 (1.7)
0.26
Other genetic disease A
P
3986 (98.6)
55 (1.4)
3757 (98.7)
49 (1.3)
229 (97.4)
6 (2.6)
0.18
IV. Significant maternal illness in  
     current pregnancy:
Diabetes A
P
4039 (99.5)
2 (0.5)
3805 (99.9)
1 (0.1)
234 (99.6)
1 (0.4)
RR 16.2
(CI 1.02-258.13)
Epilepsy A
P
4036 (99.9)
5 (0.1)
3801 (99.9)
5 (0.1)
235 (100.0)
0 (0.0)
>0.05
Thyroid disease A
P
4040 (100.0)
1 (0.0)
3805 (99.9)
1 (0.1)
235 (100.0)
0 (0.0)
>0.05
Heart disease A
P
4038 (99.9)
3 (0.1)
3805 (99.9)
3 (0.1)
235 (100.0)
0 (0.0)
>0.05
Chronic lung disease A
P
4038 (99.9)
3 (0.1)
3803 (99.9)
3 (0.1)
235 (100.0)
0 (0.0)
>0.05
Tuberculosis A
P
4031 (99.7)
10 (0.3)
3796 (99.7)
10 (0.3)
235 (100.0)
0 (0.0)
>0.05
Cancer A
P
4039 (100.0)
2 (0.0)
3805 (99.9)
1 (0.1)
234 (99.6)
1 (0.4)
RR 6.2
(CI 1.02-258.13)
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the programme in routine obstetric practice. Besides, 
motivation, lack of appropriate infrastructure at the 
participating hospitals and logistics of travel to the 
tertiary centres and its response also came in the way. 
In case of thalassaemia screening, tracing the husbands, 
their counselling and acceptance to be tested were also 
major hurdles. 
 In spite of these limitations, around 14.0 per cent 
women who were at risk of having adverse pregnancy 
outcome were identified in this study using a simple 
questionnaire for screening women for genetic diseases 
during pregnancy. Thus this study highlights the need 
and benefit of screening women during pregnancy for 
genetic diseases. In view of the fact that around 80 per 
cent of our population live in the rural area , this calls for 
evolving and implementing a national programme with 
emphasis on screening of all pregnant women for genetic 
diseases. First step could be to develop appropriate 
information, education and communication (IEC) 
materials, combined with genetic centres/ preconception 
clinics preferably with community extension activities.
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Table  III. Distribution of outcome of pregnancy in relation to the risk factors
Increased risk (%)
N=570
Low risk  (%)
N=3471
Total
N=4041
Outcome of pregnancy:
Live birth* 517 (90.7) 3346 (96.4) 3863 (95.6)
Still birth 17 (3.0) 62 (1.8) 79 (2.0)
Spontaneous abortion* 16 (2.8) 26 (0.7) 42 (1.0)
Induced abortion* 20 (3.5) 37(1.1) 57 (1.4)
Outcome in newborn/foetus:
NTD/DS/ other malformation (foetus 
/newborn)*
17(3.0) 37(1.1) 54 (1.3)
*Statistically significant difference P<0.05
Table IV. Results of multiple logistic regression : risk factor for 
adverse outcome of pregnancy   (n=4041, 235 high risk and 3806 
non risk)
Variable/ risk factor Relative risk 95% CI
> 3 spontaneous abortion 3.9 1.77 - 9.02
H/O still birth 2.5 1.41 - 4.48
Previous child with NTD 2.3 1.22 - 4.60
Previous child with  
congenital malformation 2.2 1.11 - 4.35
(Adjusted for age, family history of disease affecting multiple 
members, previous child with genetic disease, present maternal 
illness, illnesses during first trimester of pregnancy)
V. History in 1st trimester:
Fever A
P
3951 (97.8)
90 (2.2)
3724 (97.8)
82 (2.2)
227 (99.6)
8 (3.4)
0.30
Rash A
P
4025 (99.6)
16 (0.4)
3791 (99.6)
15 (0.4)
234 (99.6)
1 (0.4)
0.61
Lymphadenopathy A
P
4039 (100.0)
2 (0.0)
3804 (99.9)
2 (0.1)
235 (100.0)
0 (0.0)
>0.05
Jaundice A
P
4030 (99.7)
11 (0.3)
3796 (99.7)
10 (0.3)
234 (99.6)
1 (0.4)
0.48
Genital ulcers A
P
4038 (99.9)
3 (0.1)
3804 (99.9)
2 (0.1)
234 (99.6)
1 (0.4)
0.16
Drug intake A
P
3988 (98.6)
53 (1.4)
3753 (98.6)
53 (1.4)
235 (100.0)
0 (0.0)
>0.05
Unprotected exposure to X-rays A
P
4038 (99.9)
3 (0.1)
3803 (99.9)
3 (0.1)
235 (100.0)
0 (0.0)
>0.05
A, absence of risk factor; P, presence of risk factor
Values in parentheses denote percentages
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